[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Advancing Myeloma Care: Immunotherapy Trials Now Underway at Sylvester Center

Advancing Myeloma Care: Immunotherapy Trials Now Underway at Sylvester Center image

Advancing Myeloma Care: Immunotherapy Trials Now Underway at Sylvester Center

Webinar
event Jun 26, 2025 / 04:00PM - 05:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join us for an informative webinar with Dickran Kazandjian, MD from the University of Miami Sylvester Comprehensive Cancer Center as he shares details about two promising clinical trials for newly diagnosed multiple myeloma patients. The Immunoplant trial explores immunotherapy as a potential alternative to stem cell transplant, using linvoseltamab (a BCMA and CD3-targeting therapy) to deepen the response of patients who are in VGPR but MRD+ after induction and the Alp d’Huez trial focused on patients in early maintenance. Learn who may qualify, how these approaches work, and what they could mean for the future of myeloma care. A Q&A session will follow the presentation.

Schedule & Agenda

The panelist Cynthia Cahoon, RN
4:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Dr. Dickran Kazandjian

The panelist Dickran Kazandjian, MD
4:05 PM
Presentation
Dickran Kazandjian, MD

Dr. Kazandjian shares details about two promising clinical trials for newly diagnosed multiple myeloma patients

Event panelist Audience
4:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Dickran Kazandjian, MD
Dickran Kazandjian, MD

Dr. Kazandjian’s clinical and translational research interests lie in the treatment of precursor plasma cell disorders including high risk smoldering multiple myeloma and the role of immunotherapy in plasma cell dyscrasias. In addition, he is re-evaluating the role of autologous stem cell transplant (ASCT) in the era of highly efficacious novel-novel drugs, immunotherapy biologics, and cell-based therapies with the hypothesis that certain subsets of patients with myeloma may not benefit by default upfront ASCT.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Amgen logo
Sanofi logo
Adaptive logo
Pfizer logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.